BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24427545)

  • 21. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
    Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
    Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells.
    Plebanek MP; Bhaumik D; Bryce PJ; Thaxton CS
    Mol Cancer Ther; 2018 Mar; 17(3):686-697. PubMed ID: 29282300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
    Yin Z; Li C; Wang J; Xue L
    Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer.
    Yang X; Lu Y; Hang J; Zhang J; Zhang T; Huo Y; Liu J; Lai S; Luo D; Wang L; Hua R; Lin Y
    Cancer Immunol Res; 2020 Nov; 8(11):1440-1451. PubMed ID: 32917658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of myeloid-derived suppressor cells in metastasis.
    Cole K; Pravoverov K; Talmadge JE
    Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage.
    Deng Y; Yang J; Qian J; Liu R; Huang E; Wang Y; Luo F; Chu Y
    Mol Immunol; 2019 Aug; 112():266-273. PubMed ID: 31212097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer.
    Wen J; Huang G; Liu S; Wan J; Wang X; Zhu Y; Kaliney W; Zhang C; Cheng L; Wen X; Lu X
    J Pathol Clin Res; 2020 Jul; 6(3):171-177. PubMed ID: 32149481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic viruses.
    Pan PY; Chen HM; Chen SH
    Oncoimmunology; 2013 Aug; 2(8):e25083. PubMed ID: 24083075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.
    Hu X; Bardhan K; Paschall AV; Yang D; Waller JL; Park MA; Nayak-Kapoor A; Samuel TA; Abrams SI; Liu K
    J Biol Chem; 2013 Jun; 288(26):19103-15. PubMed ID: 23677993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC
    Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
    Yin K; Xia X; Rui K; Wang T; Wang S
    Front Oncol; 2020; 10():610104. PubMed ID: 33384962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
    D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
    J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Dysthe M; Parihar R
    Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
    Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
    Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells.
    Diniz MO; Sales NS; Silva JR; Ferreira LC
    Mol Cancer Ther; 2016 Aug; 15(8):1920-30. PubMed ID: 27222537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.